India, Oct. 30 -- Biotech startup Helex has raised $3.5 Mn (around INR 31 Cr) in its seed funding round led by pi Ventures, with participation from a host of investors, including Bluehill.VC, US-based SOSV, among others.

The startup will deploy the capital to accelerate pre-clinical development of its lead programme, as part of which it is developing a drug to cure patients suffering from Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Besides, the capital will also be used for advancement of Helex's proprietary kidney-tropic LNP (lipid nanoparticles) delivery system and its Epic-Cure 3D genome-based drug design platform, which goes in the detail of the disease and the cells in the human body to maximise gene editing accuracy and ...